Suven Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
as on 15-02-2022
- Paid Up Capital ₹ 25.46 Cr
as on 15-02-2022
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 174.02 Cr
as on 15-02-2022
- Revenue 47.27%
(FY 2022)
- Profit 80.82%
(FY 2022)
- Ebitda 59.62%
(FY 2022)
- Net Worth 42.76%
(FY 2022)
- Total Assets 32.56%
(FY 2022)
About Suven Pharmaceuticals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543064 and on the National Stock Exchange(NSE) under SUVENPHAR.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 25.46 Cr.
The company currently has active open charges totaling ₹174.02 Cr.
The Key Managerial Personnel (KMP) at Suven Pharmaceuticals Limited India are P Rao SERVING AS THE CHIEF FINANCIAL OFFICER (CFO) and Hanumantha Kokkonda as Company Secretary. Govinda Dasu, Venkateswarlu Jasti, Srivari Chandrasekhar, and Four other members serve as directors at the Company.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Suven Pharmaceuticals Limited offer?
Suven Pharmaceuticals Limited offers a wide range of products and services, including Cleaning Chemicals, Activation Powder, Cleaning Machines & Equipments, Industrial Cleaning Machine, Syringes, Insulin Syringe.
Who are the key members and board of directors at Suven Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateswarlu Jasti  | Managing Director | 06-Nov-2019 | Current |
P Rao  | CFO(Kmp) | 10-Jan-2020 | Current |
| Hanumantha Kokkonda | Company Secretary | 10-Jan-2020 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vajja Rao | Director | 23-Jul-2021 | Current |
| Srivari Chandrasekhar | Director | 06-Nov-2019 | Current |
| Govinda Dasu | Director | 06-Nov-2018 | Current |
| Deepanwita Chattopadhyay | Director | 06-Nov-2019 | Current |
| Venkata Jasthi | Director | 06-Nov-2019 | Current |
| Jerry Jeyasingh | Director | 06-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Suven Pharmaceuticals.
Suven Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.27% increase. The company also saw a substantial improvement in profitability, with a 80.82% increase in profit. The company's net worth Soared by an impressive increase of 42.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suven Pharmaceuticals?
In 2021, Suven Pharmaceuticals had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
The Federation Of Telangana Chambers Of Commerce And IndustryActive 59 years 11 monthsVenkateswarlu Jasti is a mutual person
Suven Life Sciences LimitedActive 35 years 9 monthsVenkateswarlu Jasti and Vajja Rao are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Bahrain And Kuwait Bsc Creation Date: 29 Dec 2020 | ₹10.00 Cr | Open |
State Bank Of India Creation Date: 05 Nov 2020 | ₹164.02 Cr | Open |
How Many Employees Work at Suven Pharmaceuticals?
Suven Pharmaceuticals has a workforce of 877 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suven Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
